Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.018
Sell
RSI(14)
26.408
Sell
STOCH(KDJ)(9,3,3)
8.236
Oversold
ATR(14)
0.111
Low Volatility
CCI(14)
-132.996
Sell
Williams %R
95.000
Oversold
TRIX(12,20)
-0.899
Sell
StochRSI(14)
0.027
Sell
Petmed Express Inc
PETS2.220USD
-0.090-3.90%
Close 03/30, 16:00（ET）Quotes delayed by 15 min
47.19MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Petmed Express Inc
Currency: USD Updated: 2026-03-27Key Insights
Petmed Express Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 24 out of 30 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Sell, with the highest price target at 2.75.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Petmed Express Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Petmed Express Inc Highlights
StrengthsRisks
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Overvalued
The company’s latest PE is -0.72, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 7.97M shares, decreasing 28.96% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 1.23M shares of this stock.
Analyst Rating
Based on
1
analysts
Sell
Current Rating
2.750
Target Price
+19.05%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-03-27The current financial score of Petmed Express Inc is 7.02, ranking 17 out of 30 in the Food & Drug Retailing industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 40.66M, representing a year-over-year decrease of 23.26%, while its net profit experienced a year-over-year decrease of 1392.64%.
Score
Financials
7.28
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Operational Efficiency
6.43
Growth Potential
5.29
Shareholder Returns
6.09
Petmed Express Inc's Company Valuation
Currency: USD Updated: 2026-03-27The current valuation score of Petmed Express Inc is 7.97, ranking 15 out of 30 in the Food & Drug Retailing industry. Its current P/E ratio is -0.72, which is -50563.15% below the recent high of 361.37 and -48441.70% above the recent low of -347.61.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 24/30
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-03-27The current earnings forecast score of Petmed Express Inc is 4.00, ranking 20 out of 30 in the Food & Drug Retailing industry. The average price target is 2.75, with a high of 2.75 and a low of 2.75.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
1
analysts
Sell
Current Rating
2.750
Target Price
+23.32%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
5
Total
1
Median
1
Average
Company name
Ratings
Analysts
Petmed Express Inc
PETS
1
Guardian Pharmacy Services Inc
GRDN
4
High Tide Inc
HITI
1
Walgreens Boots Alliance Inc
WBA
0
IM Cannabis Corp
IMCC
0
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-03-27The current price momentum score of Petmed Express Inc is 5.70, ranking 25 out of 30 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 2.63 and the support level at 2.02, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.272
Sell
MA10
2.360
Sell
MA20
2.463
Sell
MA50
2.820
Sell
MA100
2.735
Sell
MA200
2.871
Sell
Institutional Confidence
Currency: USD Updated: 2026-03-27The current institutional shareholding score of Petmed Express Inc is 3.00, ranking 16 out of 30 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 37.30%, representing a quarter-over-quarter decrease of 1.13%. The largest institutional shareholder is James Simons, holding a total of 1.23M shares, representing 5.73% of shares outstanding, with 7.59% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
SilverCape Investments Ltd.
Nina Capital Holdings Inc
Federated MDTA LLC
BlackRock Institutional Trust Company, N.A.
Dimensional Fund Advisors, L.P.
1
2
Risk Assessment
Currency: USD Updated: 2026-03-27The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Petmed Express Inc is 1.35, ranking 28 out of 30 in the Food & Drug Retailing industry. The company's beta value is 0.77. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Petmed Express Inc’s latest ESG disclosure leads the Food & Drug Retailing industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
Score
Beta vs S&P 500 index
0.79
VaR
+4.96%
240-Day Maximum Drawdown
+61.81%
240-Day Volatility
+82.13%
Return
Best Daily Return
60 days
+8.53%
120 days
+68.36%
5 years
+68.36%
Worst Daily Return
60 days
-5.60%
120 days
-32.59%
5 years
-32.59%
Sharpe Ratio
60 days
-3.61
120 days
+0.31
5 years
-0.53
Risk Assessment
Maximum Drawdown
240 days
+61.81%
3 years
+89.97%
5 years
+95.49%
Return-to-Drawdown Ratio
240 days
-0.43
3 years
-0.32
5 years
-0.20
Skewness
240 days
+5.55
3 years
+4.51
5 years
+4.52
Volatility
Realised Volatility
240 days
+82.13%
5 years
+60.63%
Standardised True Range
240 days
+7.70%
5 years
+23.99%
Downside Risk-Adjusted Return
120 days
+66.16%
240 days
+66.16%
Maximum Daily Upside Volatility
60 days
+38.61%
Maximum Daily Downside Volatility
60 days
+26.34%
Liquidity
Average Turnover Rate
60 days
+0.70%
120 days
+0.74%
5 years
--
Turnover Deviation
20 days
-59.01%
60 days
-52.76%
120 days
-50.29%
Peer Comparison
Food & Drug Retailing
Petmed Express Inc
PETS
5.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bbb Foods Inc
TBBB
8.14 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Guardian Pharmacy Services Inc
GRDN
8.02 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Kroger Co
KR
7.92 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Performance Food Group Co
PFGC
7.88 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Albertsons Companies Inc
ACI
7.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
